✦ LIBER ✦

Clinical markers of therapeutic response to disease modifying drugs

✍ Scribed by Carlo Pozzilli; Luca Prosperini

Publisher: Springer Milan
Year: 2008
Tongue: English
Weight: 32 KB
Volume: 29
Category: Article
ISSN: 1590-1874
DOI: 10.1007/s10072-008-0939-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lessons learned from nine clinical trial

Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs

✍ Kenneth D. Brandt; Steven A. Mazzuca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

Clinical and radiographic outcomes of rh

Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs

✍ Mahmoud Abu-Shakra; Rita Toker; Daniel Flusser; Gideon Flusser; Michael Friger; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Cost-effectiveness of biologic response

Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review

✍ Gabrielle van der Velde; Ba' Pham; Márcio Machado; Luciano Ieraci; William Witte 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 172 KB 👁 2 views

Importance of benefit-to-risk assessment

Importance of benefit-to-risk assessment for disease-modifying drugs used to treat MS

✍ Gordon S. Francis 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 216 KB

Interleukin-6 receptor inhibition with t

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

✍ Mark C. Genovese; James D. McKay; Evgeny L. Nasonov; Eduardo F. Mysler; Nilzio A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Clinical usefulness of therapeutic drug

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

✍ Melissa L. Haines; Yousef Ajlouni; Peter M. Irving; Miles P. Sparrow; Rosemary R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Background: Circulating concentrations of 6-thioguanine nucleotide (6-TGN) and 6-methyl mercaptopurine (6-MMP) are associated with thiopurine efficacy and may predict toxicity. This study aimed to examine retrospectively the utility of measuring metabolite concentrations in patients with inflammator